Coagulation factor V (FV) deficiency is a rare autosomal recessive
bleeding disorder. We investigated a patient with severe FV deficiency (FV:C < 3%) and moderate
bleeding symptoms.
Thrombin generation experiments showed residual FV expression in the patient's plasma, which was quantified as 0.7 ± 0.3% by a sensitive
prothrombinase-based assay. F5 gene sequencing identified a novel missense mutation in exon 4 (c.578G>C, p.Cys193Ser), predicting the abolition of a conserved disulphide bridge, and an apparently synonymous variant in exon 8 (c.1281C>G). The observation that half of the patient's F5
mRNA lacked the last 18
nucleotides of exon 8 prompted us to re-evaluate the c.1281C>G variant for its possible effects on splicing. Bioinformatics sequence analysis predicted that this transversion would activate a cryptic donor splice site and abolish an exonic splicing enhancer. Characterization in a F5 minigene model confirmed that the c.1281C>G variant was responsible for the patient's splicing defect, which could be partially corrected by a mutation-specific
morpholino antisense oligonucleotide. The aberrantly spliced F5
mRNA, whose stability was similar to that of the normal
mRNA, encoded a putative FV mutant lacking
amino acids 427-432. Expression in COS-1 cells indicated that the
mutant protein is poorly secreted and not functional. In conclusion, the c.1281C>G mutation, which was predicted to be translationally silent and hence neutral, causes FV deficiency by impairing
pre-mRNA splicing. This finding underscores the importance of
cDNA analysis for the correct assessment of exonic mutations.